John J. Barker
Evotec (United Kingdom) · 51 works · 2,113 citations · h-index 22
Top works
- Function from structure? The crystal structure of human phosphatidylethanolamine-binding protein suggests a role in membrane signal transduction
- High-resolution structure of a potent, cyclic proteinase inhibitor from sunflower seeds
- The structure of lactate dehydrogenase from Plasmodium falciparum reveals a new target for anti-malarial design
- Engineering an intertwined form of CD2 for stability and assembly
- Binding Mode and Structure–Activity Relationships around Direct Inhibitors of the Nrf2–Keap1 Complex
- The multiple roles of computational chemistry in fragment-based drug design
- Antibacterial drug discovery and structure-based design
- Compound Design by Fragment‐Linking
- The Structure of Mammalian Serine Racemase
- Fragment screening by biochemical assay
- Fragment‐based Identification of Hsp90 Inhibitors
- Inhibitors of phosphopantetheine adenylyltransferase
- Fragment-based discovery of DNA gyrase inhibitors targeting the ATPase subunit of GyrB
- Discovery and Structure–Activity Relationship of Potent and Selective Covalent Inhibitors of Transglutaminase 2 for Huntington’s Disease
- Discovery of a Novel Hsp90 Inhibitor by Fragment Linking
- Fragment-based discovery and optimization of BACE1 inhibitors
- Tetrahydroindazoles as Interleukin-2 Inducible T-Cell Kinase Inhibitors. Part II. Second-Generation Analogues with Enhanced Potency, Selectivity, and Pharmacodynamic Modulation in Vivo
- Property- and Structure-Guided Discovery of a Tetrahydroindazole Series of Interleukin-2 Inducible T-Cell Kinase Inhibitors
- Discovery of Pyrazolopyridones as a Novel Class of Gyrase B Inhibitors Using Structure Guided Design
- Cross-linking of protein crystals as an aid in the generation of binary protein–ligand crystal complexes, exemplified by the human PDE10a–papaverine structure